🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
17.09
-0.09 (-0.52%)
Nov 18, 2026, 1:33 PM EST - Market open

Immunome Statistics

Total Valuation

Immunome has a market cap or net worth of $2.02 billion. The enterprise value is $1.57 billion.

Market Cap2.02B
Enterprise Value 1.57B

Important Dates

The last earnings date was Monday, November 9, 2026, after market close.

Earnings Date Nov 9, 2026
Ex-Dividend Date n/a

Share Statistics

Immunome has 118.07 million shares outstanding. The number of shares has increased by 37.06% in one year.

Current Share Class 118.07M
Shares Outstanding 118.07M
Shares Change (YoY) +37.06%
Shares Change (QoQ) +0.26%
Owned by Insiders (%) 1.11%
Owned by Institutions (%) 104.38%
Float 113.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 100.39
PB Ratio 4.30
P/TBV Ratio 4.49
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.66, with a Debt / Equity ratio of 0.03.

Current Ratio 11.66
Quick Ratio 11.34
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -78.71% and return on invested capital (ROIC) is -49.53%.

Return on Equity (ROE) -78.71%
Return on Assets (ROA) -45.14%
Return on Invested Capital (ROIC) -49.53%
Return on Capital Employed (ROCE) -62.57%
Weighted Average Cost of Capital (WACC) 18.79%
Revenue Per Employee n/a
Profits Per Employee -$1.06M
Employee Count267
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -6.51% in the last 52 weeks. The beta is 2.66, so Immunome's price volatility has been higher than the market average.

Beta (5Y) 2.66
52-Week Price Change -6.51%
50-Day Moving Average 20.09
200-Day Moving Average 22.08
Relative Strength Index (RSI) 37.53
Average Volume (20 Days) 1,417,763

Short Selling Information

The latest short interest is 16.17 million, so 13.70% of the outstanding shares have been sold short.

Short Interest 16.17M
Short Previous Month 17.28M
Short % of Shares Out 13.70%
Short % of Float 14.29%
Short Ratio (days to cover) 11.77

Income Statement

Revenue n/a
Gross Profit -226.54M
Operating Income -290.69M
Pretax Income -282.65M
Net Income -282.65M
EBITDA -287.50M
EBIT -290.69M
Earnings Per Share (EPS) -$2.60
Full Income Statement

Balance Sheet

The company has $461.58 million in cash and $11.39 million in debt, with a net cash position of $450.20 million or $3.81 per share.

Cash & Cash Equivalents 461.58M
Total Debt 11.39M
Net Cash 450.20M
Net Cash Per Share $3.81
Equity (Book Value) 454.30M
Book Value Per Share 4.00
Working Capital 436.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$229.03 million and capital expenditures -$9.67 million, giving a free cash flow of -$238.70 million.

Operating Cash Flow -229.03M
Capital Expenditures -9.67M
Depreciation & Amortization 3.19M
Net Borrowing n/a
Free Cash Flow -238.70M
FCF Per Share -$2.02
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Immunome does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -37.06%
Shareholder Yield -37.06%
Earnings Yield -15.21%
FCF Yield -11.71%

Analyst Forecast

The average price target for Immunome is $35.13, which is 105.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target $35.13
Price Target Difference 105.56%
Analyst Consensus Strong Buy
Analyst Count 17
Revenue Growth Forecast (3Y) 207.94%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Immunome has an Altman Z-Score of 23.91 and a Piotroski F-Score of 2.

Altman Z-Score 23.91
Piotroski F-Score 2